Pyelonephritis Treatment Market Worth USD 351.35 Million

NEW YORK, May 28, 2023 (Globe Newswire) — The pyelonephritis treatment market is poised for strong expansion, according to a recent report from Reports Insights. US$351.35 million by 2030.rated market $251.65 million in 2022, is projected to grow at CAGR 4.3% During the period 2023-2030. The report highlights the increasing adoption of pyelonephritis treatment in hospitals, accelerating market growth at the global level. Reports Insights research also provides insights into the market competitive landscape, market segmentation, regional outlook, and emerging technologies in the Pyelonephritis Treatment Market.

Global players in the pyelonephritis therapeutics industry are increasingly exploiting the technological potential in developing a new range of pyelonephritis therapeutics, increasing their product offerings in the global market. As a result, pyelonephritis treatment manufacturers with a global presence are investing in developing new methods with the latest technological advances to ensure the development of new pyelonephritis treatments. Therefore, the launch of new pyelonephritis therapeutics with upgraded technology is leading to the growth of the pyelonephritis treatment market.

Apply for free sample report@

For example, in June 2020, Pfizer received FDA approval of BAVENCIO for the treatment of patients with pyelonephritis. Therefore, increasing development of new technologies for pyelonephritis treatment by various global companies to enhance drug efficacy is a key factor amplifying the growth of the global pyelonephritis treatment market.

Additionally, an increasing pipeline of pyelonephritis treatments focused on minimizing the impact and spread of pyelonephritis will drive commercialization and expanded product offerings in the global pyelonephritis market. Therefore, the recent pipeline for pyelonephritis treatment will create positive growth prospects for the pyelonephritis market.

Details of the Global Pyelonephritis Treatment Market Segmentation:

Based on treatment type The plazomycin segment contributed the highest market share in 2022. Plazomycin is an effective treatment against carbapenemases and certain other hydrolases produced by a variety of bacteria. Moreover, plazomycin for the treatment of pyelonephritis achieves a higher combined cure rate compared with meropenem. Therefore, it is an ideal treatment for pyelonephritis. Going forward, this sector is expected to register good growth during the forecast period, owing to the above mentioned advantages of plazomycin.

Based on end user The hospitals and clinics sector is expected to account for a large share of the global pyelonephritis treatment market. Hospital doctors often prescribe medications for pyelonephritis, such as antibiotics and pain relievers, to ensure that kidney-related complications are alleviated. Prolonged pyelonephritis can lead to serious illnesses such as hypertension and kidney failure. As a result, there is increasing adoption of pyelonephritis treatment modalities in hospitals to stop the spread of the disease, which fuels the growth of the market.

based on region, in 2022, North America accounted for the largest share contribution to the market growth. Key factors such as increased R&D activities related to drug discovery for pyelonephritis, favorable reimbursement scenarios, etc. are fueling the growth of the pyelonephritis market in the North America region.

Report attributes Report details
Market size by 2030
Forecast period
CAGR (2023-2030)
base year
Research schedule
key player Melinta Therapeutics LLC, Cipla Inc., Allecra Therapeutics, Pfizer Inc., Allergan, Spero Therapeutics, MerLion Pharmaceuticals GmbH, Merck & Co., Inc., Bayer AG, Sanofi
By treatment type
  • Plazomycin
  • Levofloxacin
  • Meropenem and Vaborbactam
  • others
By end user
  • hospital
  • home care
  • Specialized clinic
  • others
Report scope Company rankings and market shares, growth drivers, total revenue forecasts, regional competitive landscape, business strategies, and more.
by geography North America, Asia Pacific, Latin America, Europe, Middle East, Africa

See full report including Table of Contents (TOC) @

Important points in the market

  • From an end-user perspective, the hospital segment is expected to account for a major share in the growth of the pyelonephritis treatment market statistics during the forecast period.
  • North America will create favorable conditions for market growth in terms of value, owing to the growing development of medical facilities for pyelonephritis treatment, especially in countries such as the United States.
  • The global pyelonephritis treatment market size is estimated to exceed USD 351.35 million by 2030, at a staggering CAGR of 4.3% during the forecast period (2023-2030).
  • Based on treatment type, plazomycin segment accounted for the highest share contribution in 2022 pyelonephritis treatment market statistics.

competitive environment

According to the research, Sanofi, Pfizer, Cipla, etc. are the major market players that make up the latest market landscape. These companies have strong production capabilities and a strong market presence through their extensive product portfolios and distribution networks. Moreover, the pyelonephritis treatment market is expected to grow steadily, owing to rising demand from specialty clinic end-users, especially in the Asia-Pacific, North America, and Europe regions, which is estimated to boost the market statistics in the coming years. It has been. In addition, strategic alliances for the development of a new range of pyelonephritis therapeutics will further increase competition in the market.

Inquiry or Customization Request@

Recent developments

  • In September 2022, Spero Therapeutics and GSK entered into an exclusive licensing agreement for tevipenem HBr, a late-stage antibiotic for the treatment of pyelonephritis. The increase in licenses will therefore accelerate product offerings for the treatment of pyelonephritis at a global level over the next few years.

List of Major Global Pyelonephritis Treatment Market:

  • Melinta Therapeutics LLC
  • Cipla Co., Ltd.
  • Arecra Therapeutics
  • Pfizer Japan Inc
  • Allergan
  • Spero Therapeutics
  • Merlion Pharmaceuticals GmbH
  • Merck
  • Bayer AG
  • Sanofi

Global Pyelonephritis Treatment Market Segmentation:

  • By treatment type
    • Plazomycin
    • Levofloxacin
    • Meropenem and Vaborbactam
    • others
  • By end user
    • hospital
    • home care
    • Specialized clinic
    • others

Frequently Asked Questions of the Pyelonephritis Treatment Market Report

What will be the market size of the Pyelonephritis Treatment industry in 2020?

What will be the potential market value of the pyelonephritis treatment industry by 2030?

What are the key factors driving the growth of the Pyelonephritis Treatment market and the opportunities that may influence the future development of the market?

What are the dominant segments by treatment type in the Pyelonephritis Treatment Market?

Based on current market trends and future projections, which geographic regions will have the fastest impact on the growth of the pyelonephritis treatment market over the next few years?

Discover more with report insights Library of others research report:-

Downstream market Extensive demand and growth to 2030

Capacitive sensor market Detailed analysis and regional forecasts to 2030

Smart material market Total scale, growth to 2030

CMOS image sensor market Forecast to 2030 – Demand, Growth and Scale Forecasts

Industrial valve market Demand by 2030

Liquid analyzer market Detailed analysis to 2030

Mass dispensing system market Forecast to 2030

About Reports Insights Consulting Pvt Ltd

ReportsInsights Consulting Pvt Ltd. is a leading research industry provider of contextual, data-centric research services to clients worldwide. The firm helps clients strategize business policies and achieve sustainable growth in their respective market areas. The industry offers consulting services, syndicated research reports, and customized research reports.

To understand the regional and global commercial landscape, leading research institutes and institutions Report Insights Consulting Pvt Ltd. Our reports consist of detailed analysis and statistical analysis on various industries in major countries around the world.



united states of america: +1-214-272-0393

Europe: +44-20-8133-9198


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *